Sagimet Biosciences

0 followers


Sagimet Biosciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat important diseases such as the liver disease NASH and specific cancers, with focus on targeting dysfunctional metabolic pathways.

Employees

11-50

Links

Org chart

David Happel
CEO & Director

David Happel

Collapse
Eduardo Bruno Martins
Chief Medical Officer
Elizabeth Rozek
General Counsel & Chief Compliance Officer
Marie O’Farrell
SVP of Research & Development
Katharine Grimmer
Senior Vice President
Wen-Wei Tsai
Senior Director, Translational Sciences

Board & advisors

Jinzi J. Wu
Director
Elizabeth J. Parks
Scientific Advisor
Scott Friedman
Scientific Advisor
Rohit Loomba
Scientific Advisor
Stephen A. Harrison
Scientific Advisor